MedTech considers drug device challenges
Following a positive response to BioPhorum’s proposal for a new collaboration in the combination products space, representatives from eight BioPhorum member companies gathered in early May to agree a plan for developing a MedTech Phorum program. Ten stakeholders joined the kick-off call and brought more than 125 years of combination product experience spanning functions across the full product lifecycle, including device design and engineering, clinical development, commercialization, packaging and supply chain, quality oversight, regulatory compliance and patient safety.
During Q2/Q3, the team will take a deeper dive into several topic areas, including drug device co-development, regulatory compliance, device design, digital healthcare and the supply chain. The aim is to define a series of problem statements that will then be prioritized and used to develop workstream charters. The team is due to meet again in early June when it will focus on the challenges of drug device co-development.
If you or any of your colleagues are involved in combination product development, manufacture or regulation and would like to know more about this work, please contact email@example.com. The team is especially keen to work with experts in connected/digital device development and regulation.
BioPhorum MedTech launch program
LONG READSpeed to Clinic initiative launches: learning from the COVID-19 pandemic Spurred on by lessons learned from...